Trial intelligence / Profile preview

MenACWY Liquid Formulation vs Menveo in Adolescents and Young Adults

NCT03433482Phase 2Completed

Sponsor
GSK
Start
Aug 2018
Primary completion
Jul 2019
Modality
Vaccines & Immunotherapeutics
Countries
9
01

Overview

A Phase 2 trial of Meningococcal ACWY conjugate vaccine in meningococcal infection, sponsored by GSK. Started Aug 2018; status: completed.

02

Drugs

Meningococcal ACWY conjugate vaccine
03

Conditions

meningococcal infection

Beyond the preview

Go deeper on NCT03433482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03433482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call